Litcius/Paper detail

2,3-Dihydro-1,3,4-thiadiazoles as dual B-Raf / VEGFR-2 inhibitors: Design, synthesis, and anti-breast cancer assessment

Walid E. Elgammal, Hazem Elkady, Hazem A. Mahdy, Alaa Elwan, Dalal Z. Husein, Fatma G. Amin, Bshra A. Alsfouk, Eslam B. Elkaeed, Ibrahim H. Eissa, Ahmed M. Metwaly

2025Journal of Molecular Structure5 citationsDOI

Topics & Concepts

ChemistryBreast cancerCancerApoptosisCancer researchIn vitroCancer cellLead compoundCell cycle checkpointPharmacologyCytotoxic T cellKinaseHuman breastStructure–activity relationshipCytotoxicityPharmacokineticsSmall moleculeDual (grammatical number)Cancer cell linesCell cultureCell growthBiological activityInhibitory postsynaptic potentialCellCell cycleIC50Synthesis and biological activityAngiogenesis and VEGF in CancerMelanoma and MAPK Pathways
2,3-Dihydro-1,3,4-thiadiazoles as dual B-Raf / VEGFR-2 inhibitors: Design, synthesis, and anti-breast cancer assessment | Litcius